Recurrent erysipelas: predisposing factors and costs of prophylaxis

Clicks: 396
ID: 117101
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #5 of 14 articles by views in Infection

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
After an average follow-up time of three years, recurrent erysipelas was observed in 29% of 143 patients admitted primarily with erysipelas. Nineteen patients (13%) had two or more recurrences during this period. The predisposing factor with the highest recurrence rate was venous insufficiency. Regu …
Reference Key
c1970infectionrecurrent Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jorup-Rönström C;Britton S;;
Journal Infection
Year 1970
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/3110071
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female male aged middle aged Recurrence anti-bacterial agents / therapeutic use risk cost-benefit analysis erysipelas / drug therapy erysipelas / etiology* c jorup-rönström s britton pmid:3110071 doi:10.1007/bf01650206 internal medicine infectious diseases general practice / family medicine

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.